User profiles for Mark Emberton

Mark Emberton

Professor of Interventional Oncology, University College London, UK
Verified email at ucl.ac.uk
Cited by 42053

[HTML][HTML] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

…, AP Kirkham, R Oldroyd, C Parker, M Emberton - The Lancet, 2017 - thelancet.com
Background Men with high serum prostate specific antigen usually undergo transrectal
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including …

How good is MRI at detecting and characterising cancer within the prostate?

APS Kirkham, M Emberton, C Allen - European urology, 2006 - Elsevier
OBJECTIVES: As well as detecting prostate cancer, it is becoming increasingly important to
estimate its location, size and grade. We aim to summarise current data on the efficacy of …

Benign prostatic hyperplasia: a progressive disease of aging men1

M Emberton, GL Andriole, J De La Rosette, B Djavan… - Urology, 2003 - goldjournal.net
Benign prostatic hyperplasia (BPH) represents a considerable health problem to aging men
through its associated signs, symptoms, and complications. Although not a life-threatening …

[HTML][HTML] Systematic review of complications of prostate biopsy

S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton… - European urology, 2013 - Elsevier
Context Prostate biopsy is commonly performed for cancer detection and management. The
benefits and risks of prostate biopsy are germane to ongoing debates about prostate cancer …

[HTML][HTML] MRI-targeted or standard biopsy for prostate-cancer diagnosis

…, J Deeks, Y Takwoingi, M Emberton… - … England Journal of …, 2018 - Mass Medical Soc
Background Multiparametric magnetic resonance imaging (MRI), with or without targeted
biopsy, is an alternative to standard transrectal ultrasonography–guided biopsy for prostate-…

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting

…, B Tombal, A Villers, J Van Der Meulen, M Emberton - European urology, 2011 - Elsevier
… : Hashim Ahmed and Mark Emberton receive funding … Mark Emberton receives funding in
part from the UCL/UCLH NIHR Comprehensive Biomedical Research Centre. Mark Emberton

Early detection of cancer

…, KM Brindle, LM Coussens, C Dive, M Emberton… - Science, 2022 - science.org
Survival improves when cancer is detected early. However, ~50% of cancers are at an advanced
stage when diagnosed. Early detection of cancer or precancerous change allows early …

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction

M Oelke, A Bachmann, A Descazeaud, M Emberton… - European urology, 2013 - Elsevier
OBJECTIVE: To present a summary of the 2013 version of the European Association of
Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS). …

Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review

…, M Emberton, B Ehdaie, BA Hadaschik, LS Marks… - European urology, 2015 - Elsevier
Mark Emberton and Hashim U. Ahmed would like to acknowledge funding from the Medical
Mark Emberton receives funding in part from the UK National Institute of Health Research …

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)

…, G Alivizatos, J Nordling, CR Sanz, M Emberton… - European urology, 2004 - Elsevier
OBJECTIVE:: To provide the first update of the EAU guidelines on assessment, therapy and
follow-up of men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic …